RPAP3: A Potential Drug Target for Protein Degradation and Cellular Processes

Target Name: RPAP3

NCBI ID: G79657

RPAP3

RPAP3: A Potential Drug Target for Protein Degradation and Cellular Processes

RNA-protein interactions are a crucial aspect of gene regulation and have been implicated in numerous cellular processes. One such interaction is between RNA-protein interactions and protein degradation, which is regulated by the protein RPAP3 (regulatory associated protein of RNA-protein interactions) . RPAP3 is a protein that plays a critical role in regulating the stability of RNA-protein interactions and is therefore considered a potential drug target (or biomarker).

RPAP3 is a 44kDa protein whose encoding gene is located at HGNC11.21 in the human genome (HGNC). RPAP3 is responsible for binding and stabilizing RNA-protein interactions in cells, thereby participating in the regulation of gene expression and intracellular molecular interactions. RPAP3 plays an important role in a variety of biological processes, such as cell proliferation, differentiation, and tumor formation.

In recent years, researchers have conducted in-depth studies on the functions of RPAP3. They found that RPAP3 is closely related to protein degradation in many biological processes. For example, RPAP3 can bind and stabilize RNA-protein interactions, thereby inhibiting protein degradation. In addition, RPAP3 can also bind DNA and participate in the degradation of DNA-binding proteins, thereby regulating gene expression.

In addition, RPAP3 also plays an important role in cellular stress response. Studies have shown that RPAP3 can bind and stabilize RNA-protein interactions, thereby alleviating cellular stress responses. RPAP3 can also bind intracellular molecules, such as histamine, and participate in the regulation of cellular stress responses.

RPAP3 also plays an important role in tumorigenesis. Research shows that RPAP3 can bind and stabilize RNA-protein interactions, thereby promoting the growth and spread of tumor cells. In addition, RPAP3 can also bind to proteins, such as p21, and participate in the regulation of tumor cell growth and spread.

RPAP3 also plays an important role in cell differentiation. Studies have shown that RPAP3 can bind and stabilize RNA-protein interactions, thereby participating in the regulation of cell differentiation. RPAP3 can also bind to proteins, such as Myap2, and participate in the regulation of cell differentiation.

RPAP3 also plays an important role in neurodevelopment. Studies have shown that RPAP3 can bind and stabilize RNA-protein interactions, thereby participating in the regulation of neural development. RPAP3 can also bind to proteins, such as Trpm2, and participate in the regulation of neural development.

In summary, RPAP3 is a protein that plays an important role in biological processes. Because RPAP3 is closely related to protein degradation in many biological processes, it is a potential drug target (or biomarker). In the future, researchers will continue to study the functions of RPAP3 in depth and explore the application prospects of RPAP3 in drug development.

Protein Name: RNA Polymerase II Associated Protein 3

Functions: Forms an interface between the RNA polymerase II enzyme and chaperone/scaffolding protein, suggesting that it is required to connect RNA polymerase II to regulators of protein complex formation

The "RPAP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPAP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets